MENU
ATYR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
aTyr Pharma (ATYR) Ownership - Who owns aTyr Pharma?
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
258.54M
P/E Ratio
N/A
Total Cash
65.99M
Projected Growth
N/A
Total Debt
13.57M
Revenue
235K
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash/Share
0.79
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
ATYR
Capitalization
259M
P/E Ratio
N/A
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash
66M
Total Cash/Share
0.79
Total Debt
13.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
235K
ROE
N/A
Book Value
65.3M
P/B Ratio
3.96
Cash Flow
N/A
Earnings
-0.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
76K
Current Ratio
5.41
Current Revenue Per Employee
3983.05
Dividends Per Share - Security
N/A
EBITDA
-66.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-58.90
Shares Held By Institutions
166M
Shares Outstanding - Current
83.9M
Total Liabilities
26.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
118.440
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information